FDA OKs Dexycua Intraocular Suspension for Cataract Surgery FDA OKs Dexycua Intraocular Suspension for Cataract Surgery

Dexycu, which is administered as a single injection immediately after surgery, eliminates the need for patients to use eyedrops following cataract surgery.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news